Telmisartan and Listless - a phase IV clinical study of FDA data

Summary:

Listless is reported as a side effect among people who take Telmisartan (telmisartan), especially for people who are female, 60+ old, also take Amlodipine Besylate, and have Pain.

The phase IV clinical study analyzes which people have Listless when taking Telmisartan. It is created by eHealthMe based on reports of 8,644 people who have side effects when taking Telmisartan from the FDA, and is updated regularly.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.

What is Listless?

Listless (lack of interest, energy, or spirit) is found to be associated with 456 drugs and 653 conditions by eHealthMe. Check the latest studies of Listless.

On Aug, 09, 2026

8,644 people reported to have side effects when taking Telmisartan.
Among them, 32 people (0.37%) have Listless.

Among these 32 people:

What is the gender of people who have Listless when taking Telmisartan? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Listless when taking Telmisartan? *

What are other drugs people take besides Telmisartan? *

What are other side effects people have besides Listless? *

Dizziness: 30 people, 93.75%
Fall: 30 people, 93.75%
Stress And Anxiety: 30 people, 93.75%
Apathy: 29 people, 90.62%
Oxygen Saturation Decreased: 28 people, 87.50%
Head Discomfort: 28 people, 87.50%
Nausea (feeling of having an urge to vomit): 28 people, 87.50%
Urinary Retention (the inability to completely or partially empty the bladder): 28 people, 87.50%
Delirium (wild excitement): 28 people, 87.50%
Confusional State: 28 people, 87.50%

What are the existing conditions these people have? *

Pain: 28 people, 87.50%
Constipation: 27 people, 84.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 27 people, 84.38%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 27 people, 84.38%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 27 people, 84.38%
Nausea (feeling of having an urge to vomit): 24 people, 75.00%
Calcium Deficiency (lack of calcium): 24 people, 75.00%
Encephalopathy (functioning of the brain is affected by some agent or condition): 24 people, 75.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 23 people, 71.88%
Neuralgia (pain in one or more nerves): 6 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Telmisartan and have Listless?

- Check whether Listless is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Telmisartan:

Telmisartan (9,163 reports)

Listless treatments and more:

Listless (4,524 reports)

Browse all side effects of Telmisartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Listless:

Listless (456 drugs)

Browse all the conditions that are associated with Listless:

Listless (653 conditions)

Related publications that referenced our studies

Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan (the active ingredients of Telmisartan) and Telmisartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.